TENOFOVIR DISOPROXIL FUMARATE | N022577 | GILEAD SCIENCES INC
Lowest Price
$440.97
Highest Price
$440.97
FSS NDCs
1
Big4 NDCs
1
| Description | Price | Type | Vendor | Contract End |
|---|---|---|---|---|
| 61958-0403-01VIREAD 40MG ORAL POWDER | $440.97 | Big4 | Gilead Sciences, Inc. | 09/29/2026 |
| 61958-0403-01VIREAD 40MG ORAL POWDER | $440.97 | FSS | Gilead Sciences, Inc. | 09/29/2026 |
Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.
26 active API suppliers hold Drug Master Files for this ingredient.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
| Date | Submission | Document |
|---|---|---|
| Apr 24, 2019 | SUPPL -14 | View Letter (PDF) |
| Dec 20, 2018 | SUPPL -13 | View Letter (PDF) |
| Apr 12, 2017 | SUPPL -11 | View Letter (PDF) |
| Feb 18, 2016 | SUPPL -9 | View Letter (PDF) |
| Jun 2, 2015 | SUPPL -7 | View Letter (PDF) |
| Oct 25, 2013 | SUPPL -6 | View Letter (PDF) |
| Jul 26, 2013 | SUPPL -3 | View Letter (PDF) |
| Apr 3, 2013 | SUPPL -4 | View Letter (PDF) |
| Aug 20, 2012 | SUPPL -2 | View Letter (PDF) |
| Aug 9, 2012 | SUPPL -1 | View Letter (PDF) |
| Jan 31, 2012 | ORIG -1 | View Letter (PDF) |
Source: Drugs@FDA application documents.
No patent or exclusivity listings for this strength.